Cargando…
Chondroitin Sulfate-Modified Liposomes for Targeted Co-Delivery of Doxorubicin and Retinoic Acid to Suppress Breast Cancer Lung Metastasis
Breast cancer treatment remains challenging due to high levels of cell metastasis. Chemotherapy drug combinations can inhibit both tumor growth in situ and metastasis to distant organs. Therefore, here, we developed chondroitin sulfate liposomes (CSLs) as a carrier for the co-delivery of retinoic ac...
Autores principales: | Zhang, Zhiwei, Ma, Lixin, Luo, Jingwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003575/ https://www.ncbi.nlm.nih.gov/pubmed/33808649 http://dx.doi.org/10.3390/pharmaceutics13030406 |
Ejemplares similares
-
Smart Chondroitin Sulfate Micelles for Effective Targeted Delivery of Doxorubicin Against Breast Cancer Metastasis
por: Yu, Jingmou, et al.
Publicado: (2023) -
Development of a Biomimetic Chondroitin Sulfate-modified Hydrogel to Enhance the Metastasis of Tumor Cells
por: Liu, Yang, et al.
Publicado: (2016) -
Self-assembled poly(ε-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cells
por: Lin, Yue-Jin, et al.
Publicado: (2012) -
Chondroitin Sulfate and Fucosylated Chondroitin Sulfate as Stimulators of Hematopoiesis in Cyclophosphamide-Induced Mice
por: Ustyuzhanina, Nadezhda E., et al.
Publicado: (2021) -
A Highly Active Chondroitin Sulfate Lyase ABC for Enzymatic Depolymerization of Chondroitin Sulfate
por: Fan, Xiao-Man, et al.
Publicado: (2022)